Bupropion vs Durvalumab

Bupropion vs Durvalumab: Overview

This comparison examines the pharmacological differences between Bupropion and Durvalumab.

Mechanism of Action

Bupropion: Norepinephrine-dopamine reuptake inhibitor (NDRI).

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Pharmacokinetics

Half-life: Bupropion — 21 hours; Durvalumab — 17 days.

Chemical Properties

Molecular Formula: Bupropion — C13H18ClNO.

Molecular Weight: Bupropion — 239.7420 g/mol.

Type: Bupropion — Small molecule; Durvalumab — Antibody.